https://www.selleckchem.com/pr....oducts/eribulin-mesy
3%, specificity 98.6%]. The MPL-ANN model based on six optimal parameters exhibited better diagnostic and predict performance (AUC=0.984, 95% CI 0.960-1.00, sensitivity 92.7%, specificity 93.3%, accuracy 93.0%) than the PLS-DA model based on five optimal parameters (AUC=0.912, 95% CI 0.853-0.971, sensitivity 87.8%, specificity 84.4%, accuracy 84.8%) in discriminating MAP patients from SAP patients. The results demonstrated that the MPL-ANN model based on routine blood and serum biochemical indexes provides a reliable and
Curtir
Comentario
Compartilhar
